Analysts See $0.47 EPS for Acadia Healthcare Company, Inc. (ACHC)

April 20, 2018 - By Maria Brooks

Investors sentiment decreased to 0.92 in Q4 2017. Its down 0.59, from 1.51 in 2017Q3. It is negative, as 54 investors sold Acadia Healthcare Company, Inc. shares while 76 reduced holdings. 46 funds opened positions while 74 raised stakes. 104.36 million shares or 3.18% less from 107.79 million shares in 2017Q3 were reported.
Ls Inv Ltd Liability holds 0.01% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) or 5,698 shares. Mufg Americas Holdg invested in 0% or 583 shares. Wellington Mngmt Gp Limited Liability Partnership holds 0.06% or 8.77 million shares in its portfolio. Price T Rowe Assocs Md stated it has 10.96M shares. Amalgamated Bancorporation holds 0.01% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) or 15,922 shares. Td Asset Mgmt holds 195,923 shares. Public Employees Retirement Association Of Colorado reported 17,302 shares or 0% of all its holdings. Frontier Cap Com Limited Liability Corp stated it has 0.69% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Segall Bryant & Hamill Ltd Liability Com owns 21,352 shares. Aristotle Capital Boston Llc accumulated 0.78% or 327,397 shares. Moreover, Tekla Capital Mgmt Limited Liability has 0.34% invested in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Credit Suisse Ag holds 0.02% or 671,728 shares. Vanguard Group Inc reported 6.77M shares or 0.01% of all its holdings. Federated Invsts Pa, Pennsylvania-based fund reported 22,289 shares. 11,119 were reported by At Bancshares.

Since December 15, 2017, it had 0 buys, and 6 sales for $13.14 million activity. Shares for $7.80 million were sold by WAUD REEVE B on Friday, March 2.

Analysts expect Acadia Healthcare Company, Inc. (NASDAQ:ACHC) to report $0.47 EPS on May, 1 after the close.They anticipate $0.01 EPS change or 2.17 % from last quarter’s $0.46 EPS. ACHC’s profit would be $41.49 million giving it 20.83 P/E if the $0.47 EPS is correct. After having $0.61 EPS previously, Acadia Healthcare Company, Inc.’s analysts see -22.95 % EPS growth. The stock decreased 0.23% or $0.09 during the last trading session, reaching $39.16. About 507,866 shares traded. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has declined 11.29% since April 20, 2017 and is downtrending. It has underperformed by 22.84% the S&P500.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Coverage

Among 9 analysts covering Acadia Healthcare (NASDAQ:ACHC), 4 have Buy rating, 0 Sell and 5 Hold. Therefore 44% are positive. Acadia Healthcare had 17 analyst reports since October 24, 2017 according to SRatingsIntel. Cantor Fitzgerald maintained the shares of ACHC in report on Wednesday, February 21 with “Hold” rating. The firm has “Neutral” rating by Credit Suisse given on Thursday, February 22. The stock has “Hold” rating by Credit Suisse on Friday, November 3. Robert W. Baird maintained it with “Hold” rating and $37.0 target in Wednesday, December 13 report. BMO Capital Markets maintained the stock with “Outperform” rating in Thursday, October 26 report. The firm has “Buy” rating given on Wednesday, October 25 by Citigroup. Mizuho maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Thursday, February 22 with “Hold” rating. Cantor Fitzgerald maintained the stock with “Neutral” rating in Wednesday, October 25 report. Mizuho maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Tuesday, October 24 with “Buy” rating. The rating was downgraded by Robert W. Baird on Wednesday, October 25 to “Hold”.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company has market cap of $3.46 billion. The company's acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It has a 17.04 P/E ratio. It also provides outpatient community services, such as community programs that are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.